20
Participants
Start Date
March 31, 2012
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Laboratory Biomarker Analysis
Correlative studies
Linsitinib
Given PO
Pharmacological Study
Correlative studies
Fox Chase Cancer Center, Philadelphia
National Institutes of Health Clinical Center, Bethesda
Sarcoma Alliance for Research Through Collaboration, Ann Arbor
University of Michigan Comprehensive Cancer Center, Ann Arbor
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Stanford Cancer Institute, Palo Alto
Oregon Health and Science University, Portland
Dana-Farber/Harvard Cancer Center, Boston
National Cancer Institute (NCI)
NIH